In particular, the American Heart Association has established that C-reactive protein (CRP) is the best inflammatory marker to use as a proxy for cardiovascular disease and evidence to date supports use of CRP as an independent predictor of increased coronary heart disease risk. This evidence concerns the gene CRP and coronary artery disorder.